Evidence map›Paper›PMID 29946428›Full record

ReviewF1000Research2018

Current understanding and management of

Shamshul Ansari, Yoshio Yamaoka

Open access · goldAbstract readReview
In one paragraph

Review in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. South African Honey: Anti-International journal of food science · 2026
    Article
  3. JGH open : an open access journal of gastroenterology and hepatology · 2025
    Review
  4. International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Treatment ofHeliyon · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. DNA diagnostics for reliable and universal identification ofWorld journal of gastroenterology · 2021
    Review
  13. Anti-Molecules (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Association ofWorld journal of gastrointestinal oncology · 2020
    Article
  16. Article
  17. Article
  18. Increase in antibiotic resistantInfection and drug resistance · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Shamshul AnsariDepartment of Environmental and Preventive Medicine, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita, 879-5593, Japan.ORCID https://orcid.org/0000-0003-1846-1377
Yoshio YamaokaDepartment of Environmental and Preventive Medicine, Oita University Faculty of Medicine, 1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita, 879-5593, Japan.
Baylor College of Medicine · USOita University · JP

Funding

REGULATION OF CXC CHEMOKINE EXPRESSION BY H. PYLORIR01DK062813 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI YAMAOKA, YOSHIO · 2004 to 2013
$3.0M
NIDDK NIH HHS R01 DK062813
6 · The paper itself

Abstract

In addition to its role in gastric conditions,

Indexed as

antibiotics resistanceeradication therapyHelicobacter pylorivirulence factors

Identifiers

PMID29946428
PMCPMC5998008
OpenAlexW2808623276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.